 Rui Zhao
Concepts (279)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Protein Tyrosine Phosphatases | 15 | 2025 | 167 | 4.220 |
Why?
| | Spliceosomes | 11 | 2021 | 54 | 2.660 |
Why?
| | RNA Splicing | 8 | 2024 | 284 | 2.530 |
Why?
| | RNA Precursors | 8 | 2024 | 154 | 2.510 |
Why?
| | Saccharomyces cerevisiae | 8 | 2024 | 573 | 2.060 |
Why?
| | Alcohol Oxidoreductases | 7 | 2021 | 61 | 1.870 |
Why?
| | DNA-Binding Proteins | 12 | 2025 | 1480 | 1.860 |
Why?
| | Protein Phosphatase 2 | 3 | 2025 | 41 | 1.820 |
Why?
| | Intracellular Signaling Peptides and Proteins | 9 | 2024 | 456 | 1.440 |
Why?
| | Saccharomyces cerevisiae Proteins | 7 | 2024 | 414 | 1.420 |
Why?
| | Ribonucleoprotein, U1 Small Nuclear | 2 | 2024 | 20 | 1.360 |
Why?
| | Nuclear Proteins | 9 | 2024 | 740 | 1.240 |
Why?
| | Cryoelectron Microscopy | 5 | 2025 | 221 | 1.140 |
Why?
| | Peptides | 3 | 2025 | 998 | 1.080 |
Why?
| | Proto-Oncogene Proteins c-myc | 3 | 2025 | 167 | 1.070 |
Why?
| | Ribonucleoprotein, U4-U6 Small Nuclear | 4 | 2015 | 10 | 0.970 |
Why?
| | RNA | 4 | 2023 | 910 | 0.960 |
Why?
| | Introns | 4 | 2021 | 255 | 0.890 |
Why?
| | DEAD-box RNA Helicases | 2 | 2020 | 83 | 0.870 |
Why?
| | Thrombectomy | 1 | 2025 | 78 | 0.850 |
Why?
| | RNA Helicases | 3 | 2015 | 27 | 0.830 |
Why?
| | Rosaniline Dyes | 1 | 2024 | 15 | 0.820 |
Why?
| | Protein Binding | 17 | 2025 | 2238 | 0.760 |
Why?
| | High-Throughput Screening Assays | 3 | 2014 | 176 | 0.730 |
Why?
| | Crystallography, X-Ray | 8 | 2019 | 486 | 0.700 |
Why?
| | Thrombosis | 1 | 2025 | 400 | 0.670 |
Why?
| | Models, Molecular | 10 | 2019 | 1598 | 0.660 |
Why?
| | Robotics | 1 | 2022 | 90 | 0.660 |
Why?
| | RNA, Small Nuclear | 4 | 2015 | 40 | 0.650 |
Why?
| | RNA, Fungal | 3 | 2017 | 67 | 0.650 |
Why?
| | Transcriptional Activation | 4 | 2021 | 372 | 0.650 |
Why?
| | Enzyme Inhibitors | 4 | 2024 | 820 | 0.620 |
Why?
| | Carrier Proteins | 3 | 2017 | 728 | 0.610 |
Why?
| | Homeodomain Proteins | 5 | 2020 | 523 | 0.600 |
Why?
| | Cell-Penetrating Peptides | 1 | 2018 | 21 | 0.550 |
Why?
| | Exons | 1 | 2019 | 363 | 0.550 |
Why?
| | Ribonucleoprotein, U5 Small Nuclear | 3 | 2013 | 11 | 0.530 |
Why?
| | Adenosine Triphosphatases | 3 | 2009 | 159 | 0.530 |
Why?
| | Neoplasm Proteins | 2 | 2018 | 441 | 0.530 |
Why?
| | Mitochondria | 1 | 2024 | 992 | 0.520 |
Why?
| | Alternative Splicing | 2 | 2017 | 247 | 0.500 |
Why?
| | Protein Structure, Tertiary | 7 | 2015 | 855 | 0.500 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2017 | 156 | 0.500 |
Why?
| | Triple Negative Breast Neoplasms | 3 | 2025 | 218 | 0.470 |
Why?
| | Branchio-Oto-Renal Syndrome | 2 | 2013 | 7 | 0.460 |
Why?
| | Neoplasms | 4 | 2024 | 2906 | 0.450 |
Why?
| | Naphthoquinones | 1 | 2014 | 20 | 0.440 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2017 | 337 | 0.430 |
Why?
| | Neoplasm Metastasis | 5 | 2025 | 688 | 0.430 |
Why?
| | Nucleic Acid Conformation | 2 | 2017 | 723 | 0.420 |
Why?
| | Adenosine Triphosphate | 5 | 2010 | 500 | 0.400 |
Why?
| | Amino Acid Sequence | 10 | 2018 | 2129 | 0.400 |
Why?
| | Molecular Sequence Data | 10 | 2014 | 2883 | 0.390 |
Why?
| | Protein Structure, Secondary | 4 | 2009 | 371 | 0.360 |
Why?
| | RNA Splice Sites | 2 | 2024 | 51 | 0.340 |
Why?
| | Transcription, Genetic | 2 | 2014 | 1454 | 0.330 |
Why?
| | DNA Helicases | 3 | 2007 | 136 | 0.320 |
Why?
| | Cell Line, Tumor | 8 | 2025 | 3542 | 0.320 |
Why?
| | Cell Movement | 2 | 2014 | 959 | 0.310 |
Why?
| | Gene Expression Regulation | 2 | 2017 | 2597 | 0.290 |
Why?
| | Pharmaceutical Preparations | 1 | 2010 | 170 | 0.280 |
Why?
| | Protein Kinases | 1 | 2010 | 312 | 0.280 |
Why?
| | Animals | 21 | 2025 | 38030 | 0.280 |
Why?
| | Topoisomerase II Inhibitors | 1 | 2008 | 24 | 0.270 |
Why?
| | Ribosomal Proteins | 1 | 2008 | 93 | 0.270 |
Why?
| | HSP90 Heat-Shock Proteins | 1 | 2008 | 46 | 0.270 |
Why?
| | Humans | 33 | 2025 | 145475 | 0.270 |
Why?
| | Macrolides | 1 | 2008 | 67 | 0.260 |
Why?
| | Antineoplastic Agents | 4 | 2024 | 2214 | 0.260 |
Why?
| | Structure-Activity Relationship | 3 | 2024 | 563 | 0.250 |
Why?
| | Gene Expression Regulation, Neoplastic | 7 | 2025 | 1443 | 0.230 |
Why?
| | Chemokine CCL2 | 1 | 2025 | 112 | 0.220 |
Why?
| | Cerebral Arteries | 1 | 2025 | 59 | 0.220 |
Why?
| | Fibrin | 1 | 2025 | 84 | 0.210 |
Why?
| | Caenorhabditis elegans Proteins | 1 | 2007 | 207 | 0.210 |
Why?
| | Hair Color | 1 | 2024 | 14 | 0.210 |
Why?
| | Saccharomycetales | 1 | 2024 | 29 | 0.210 |
Why?
| | Hyperpigmentation | 1 | 2024 | 27 | 0.200 |
Why?
| | Melanocytes | 1 | 2024 | 65 | 0.200 |
Why?
| | HEK293 Cells | 2 | 2024 | 741 | 0.200 |
Why?
| | Drug Design | 1 | 2024 | 175 | 0.190 |
Why?
| | Ribonucleoproteins, Small Nuclear | 2 | 2013 | 23 | 0.190 |
Why?
| | Tyrosine | 1 | 2024 | 217 | 0.190 |
Why?
| | NF-kappa B | 2 | 2025 | 666 | 0.190 |
Why?
| | Swine | 1 | 2025 | 825 | 0.180 |
Why?
| | Small Molecule Libraries | 2 | 2014 | 111 | 0.180 |
Why?
| | Protein Domains | 1 | 2024 | 311 | 0.180 |
Why?
| | Motion | 1 | 2022 | 94 | 0.180 |
Why?
| | Phosphorylation | 2 | 2024 | 1707 | 0.180 |
Why?
| | Killer Cells, Natural | 1 | 2025 | 480 | 0.170 |
Why?
| | Locomotion | 1 | 2022 | 101 | 0.170 |
Why?
| | Bacterial Proteins | 1 | 2008 | 967 | 0.170 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2024 | 2028 | 0.160 |
Why?
| | Eukaryotic Initiation Factor-4E | 2 | 2011 | 32 | 0.160 |
Why?
| | Anti-Inflammatory Agents | 2 | 2021 | 477 | 0.160 |
Why?
| | Protein Structure, Quaternary | 2 | 2019 | 116 | 0.160 |
Why?
| | Sequence Homology, Amino Acid | 2 | 2014 | 387 | 0.160 |
Why?
| | Psoriasis | 1 | 2021 | 115 | 0.160 |
Why?
| | Mutation | 3 | 2009 | 4075 | 0.150 |
Why?
| | Co-Repressor Proteins | 1 | 2020 | 18 | 0.150 |
Why?
| | Allosteric Regulation | 2 | 2024 | 99 | 0.150 |
Why?
| | Binding Sites | 7 | 2013 | 1310 | 0.150 |
Why?
| | Erythrocytes | 1 | 2025 | 748 | 0.150 |
Why?
| | Pulmonary Artery | 1 | 2025 | 1127 | 0.150 |
Why?
| | Mice | 9 | 2025 | 18329 | 0.140 |
Why?
| | Zinc Finger E-box-Binding Homeobox 1 | 1 | 2018 | 21 | 0.140 |
Why?
| | Substrate Specificity | 3 | 2014 | 387 | 0.140 |
Why?
| | Kinetics | 3 | 2012 | 1567 | 0.140 |
Why?
| | Protein Interaction Maps | 1 | 2018 | 51 | 0.140 |
Why?
| | MCF-7 Cells | 2 | 2020 | 133 | 0.130 |
Why?
| | Microglia | 1 | 2020 | 270 | 0.130 |
Why?
| | Cytoplasm | 2 | 2008 | 254 | 0.120 |
Why?
| | Computer Security | 1 | 2017 | 25 | 0.120 |
Why?
| | Molecular Targeted Therapy | 2 | 2017 | 439 | 0.120 |
Why?
| | RNA-Binding Proteins | 2 | 2013 | 447 | 0.120 |
Why?
| | Immune Tolerance | 1 | 2019 | 385 | 0.120 |
Why?
| | BRCA1 Protein | 2 | 2020 | 82 | 0.120 |
Why?
| | Breast Neoplasms | 4 | 2020 | 2382 | 0.120 |
Why?
| | Multiprotein Complexes | 1 | 2017 | 172 | 0.120 |
Why?
| | B7-H1 Antigen | 1 | 2018 | 244 | 0.120 |
Why?
| | Protein Conformation | 5 | 2014 | 938 | 0.110 |
Why?
| | Recombinant Fusion Proteins | 1 | 2018 | 666 | 0.110 |
Why?
| | Up-Regulation | 1 | 2018 | 847 | 0.110 |
Why?
| | Genes, Fungal | 1 | 2015 | 55 | 0.110 |
Why?
| | Interleukin-1 | 1 | 2019 | 961 | 0.110 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 2 | 2014 | 345 | 0.110 |
Why?
| | DNA Repair | 1 | 2017 | 254 | 0.110 |
Why?
| | Sequence Alignment | 3 | 2014 | 362 | 0.110 |
Why?
| | Epithelial-Mesenchymal Transition | 2 | 2020 | 219 | 0.110 |
Why?
| | Protein Unfolding | 1 | 2014 | 34 | 0.110 |
Why?
| | RNA Nucleotidyltransferases | 1 | 2014 | 22 | 0.110 |
Why?
| | DNA Damage | 1 | 2017 | 437 | 0.110 |
Why?
| | Antigens, Polyomavirus Transforming | 2 | 2004 | 15 | 0.100 |
Why?
| | Urea | 1 | 2014 | 85 | 0.100 |
Why?
| | Spectrophotometry, Ultraviolet | 1 | 2014 | 81 | 0.100 |
Why?
| | Signal Transduction | 5 | 2025 | 5216 | 0.100 |
Why?
| | Calorimetry | 1 | 2014 | 69 | 0.100 |
Why?
| | Molecular Docking Simulation | 1 | 2014 | 119 | 0.100 |
Why?
| | Repressor Proteins | 1 | 2017 | 429 | 0.100 |
Why?
| | Magnesium | 1 | 2014 | 156 | 0.100 |
Why?
| | Drug Discovery | 1 | 2014 | 153 | 0.100 |
Why?
| | Brain Injuries, Traumatic | 1 | 2020 | 453 | 0.100 |
Why?
| | Stomatitis | 1 | 2013 | 15 | 0.100 |
Why?
| | Radiation Injuries, Experimental | 1 | 2013 | 20 | 0.100 |
Why?
| | Smad7 Protein | 1 | 2013 | 20 | 0.100 |
Why?
| | Immunity, Innate | 1 | 2019 | 835 | 0.090 |
Why?
| | Cell Line | 2 | 2019 | 2823 | 0.090 |
Why?
| | Phenylhydrazines | 1 | 2012 | 4 | 0.090 |
Why?
| | Miniaturization | 1 | 2012 | 22 | 0.090 |
Why?
| | Protein Phosphatase 2C | 1 | 2012 | 15 | 0.090 |
Why?
| | Fluoresceins | 1 | 2012 | 48 | 0.090 |
Why?
| | Enzyme Assays | 1 | 2012 | 25 | 0.090 |
Why?
| | beta Catenin | 1 | 2014 | 254 | 0.090 |
Why?
| | Phosphoprotein Phosphatases | 1 | 2012 | 66 | 0.090 |
Why?
| | Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2012 | 44 | 0.090 |
Why?
| | RNA, Messenger | 2 | 2013 | 2803 | 0.090 |
Why?
| | Catalysis | 2 | 2014 | 305 | 0.090 |
Why?
| | Transforming Growth Factor beta | 2 | 2013 | 474 | 0.090 |
Why?
| | Circular Dichroism | 2 | 2014 | 151 | 0.090 |
Why?
| | DNA Replication | 2 | 2004 | 249 | 0.090 |
Why?
| | Internet | 1 | 2017 | 689 | 0.090 |
Why?
| | RNA Cap Analogs | 1 | 2011 | 6 | 0.090 |
Why?
| | Spectrometry, Fluorescence | 1 | 2012 | 165 | 0.090 |
Why?
| | Helminth Proteins | 1 | 2011 | 24 | 0.090 |
Why?
| | Peptide Chain Initiation, Translational | 1 | 2011 | 41 | 0.090 |
Why?
| | Amino Acid Motifs | 3 | 2007 | 219 | 0.090 |
Why?
| | Mice, Nude | 1 | 2013 | 679 | 0.080 |
Why?
| | Mutation, Missense | 1 | 2013 | 335 | 0.080 |
Why?
| | Peptide Fragments | 1 | 2015 | 693 | 0.080 |
Why?
| | Nanoparticles | 1 | 2017 | 517 | 0.080 |
Why?
| | Histidine Kinase | 1 | 2010 | 34 | 0.080 |
Why?
| | Jumonji Domain-Containing Histone Demethylases | 1 | 2010 | 64 | 0.080 |
Why?
| | Random Allocation | 1 | 2010 | 365 | 0.080 |
Why?
| | Cadherins | 1 | 2011 | 200 | 0.080 |
Why?
| | Hydrolysis | 2 | 2007 | 197 | 0.070 |
Why?
| | RNA Caps | 1 | 2009 | 32 | 0.070 |
Why?
| | Schistosoma mansoni | 1 | 2009 | 41 | 0.070 |
Why?
| | Base Sequence | 1 | 2013 | 2170 | 0.070 |
Why?
| | Down-Regulation | 1 | 2011 | 618 | 0.070 |
Why?
| | Salmonella typhimurium | 1 | 2010 | 188 | 0.070 |
Why?
| | Protozoan Proteins | 1 | 2009 | 90 | 0.070 |
Why?
| | Ribonuclease H | 1 | 2008 | 12 | 0.070 |
Why?
| | Female | 9 | 2025 | 78845 | 0.070 |
Why?
| | Adenylyl Imidodiphosphate | 1 | 2008 | 5 | 0.070 |
Why?
| | Novobiocin | 1 | 2008 | 4 | 0.070 |
Why?
| | Inflammation | 1 | 2020 | 2878 | 0.070 |
Why?
| | DNA Gyrase | 1 | 2008 | 8 | 0.070 |
Why?
| | Lactams, Macrocyclic | 1 | 2008 | 51 | 0.070 |
Why?
| | Benzoquinones | 1 | 2008 | 46 | 0.070 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2008 | 145 | 0.070 |
Why?
| | Cell Nucleus | 2 | 2009 | 588 | 0.070 |
Why?
| | DNA | 4 | 2010 | 1435 | 0.060 |
Why?
| | Retinitis Pigmentosa | 1 | 2007 | 20 | 0.060 |
Why?
| | Neoplastic Stem Cells | 1 | 2011 | 409 | 0.060 |
Why?
| | Catalytic Domain | 1 | 2008 | 234 | 0.060 |
Why?
| | Protein Folding | 1 | 2008 | 276 | 0.060 |
Why?
| | Crystallization | 1 | 2007 | 136 | 0.060 |
Why?
| | Reproducibility of Results | 1 | 2014 | 3413 | 0.060 |
Why?
| | Keratinocytes | 2 | 2021 | 249 | 0.060 |
Why?
| | Serine | 2 | 2023 | 143 | 0.060 |
Why?
| | Cell Proliferation | 2 | 2024 | 2507 | 0.060 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 2024 | 194 | 0.050 |
Why?
| | Kaplan-Meier Estimate | 2 | 2020 | 969 | 0.050 |
Why?
| | Protein Stability | 2 | 2018 | 176 | 0.050 |
Why?
| | Eye Proteins | 1 | 2024 | 92 | 0.050 |
Why?
| | Simian virus 40 | 1 | 2003 | 24 | 0.050 |
Why?
| | Nucleocapsid Proteins | 1 | 2023 | 28 | 0.050 |
Why?
| | Nucleocapsid | 1 | 2023 | 19 | 0.050 |
Why?
| | NIMA-Interacting Peptidylprolyl Isomerase | 1 | 2023 | 22 | 0.050 |
Why?
| | Male | 4 | 2025 | 72843 | 0.050 |
Why?
| | Receptors, Odorant | 1 | 2003 | 32 | 0.050 |
Why?
| | Molecular Structure | 1 | 2024 | 486 | 0.050 |
Why?
| | Pedigree | 1 | 2024 | 515 | 0.050 |
Why?
| | Cyclophilins | 1 | 2023 | 40 | 0.050 |
Why?
| | Escherichia coli | 1 | 2007 | 835 | 0.050 |
Why?
| | Cell Lineage | 1 | 2024 | 377 | 0.050 |
Why?
| | Tumor Suppressor Proteins | 1 | 2024 | 321 | 0.040 |
Why?
| | Arginine | 1 | 2023 | 264 | 0.040 |
Why?
| | Drosophila melanogaster | 1 | 2003 | 237 | 0.040 |
Why?
| | Immunohistochemistry | 2 | 2018 | 1716 | 0.040 |
Why?
| | Magnetic Resonance Spectroscopy | 2 | 2019 | 627 | 0.040 |
Why?
| | Hydrogen Bonding | 2 | 2014 | 169 | 0.040 |
Why?
| | Astrocytes | 1 | 2020 | 228 | 0.030 |
Why?
| | Protein Multimerization | 1 | 2019 | 204 | 0.030 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2020 | 934 | 0.030 |
Why?
| | Mice, Transgenic | 1 | 2021 | 2188 | 0.030 |
Why?
| | Phenotype | 1 | 2024 | 3155 | 0.030 |
Why?
| | Mice, Inbred C57BL | 2 | 2020 | 5983 | 0.030 |
Why?
| | Promoter Regions, Genetic | 2 | 2011 | 1246 | 0.030 |
Why?
| | Brain Neoplasms | 1 | 2024 | 1329 | 0.030 |
Why?
| | Protein Denaturation | 1 | 2014 | 76 | 0.030 |
Why?
| | Mass Spectrometry | 1 | 2018 | 730 | 0.030 |
Why?
| | rac GTP-Binding Proteins | 1 | 2013 | 35 | 0.020 |
Why?
| | rac1 GTP-Binding Protein | 1 | 2013 | 56 | 0.020 |
Why?
| | Neuropeptides | 1 | 2013 | 75 | 0.020 |
Why?
| | Macrophages | 1 | 2020 | 1507 | 0.020 |
Why?
| | Executive Function | 1 | 2017 | 470 | 0.020 |
Why?
| | Ascaris suum | 1 | 2011 | 5 | 0.020 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2018 | 919 | 0.020 |
Why?
| | RNA, Spliced Leader | 1 | 2011 | 12 | 0.020 |
Why?
| | Dinucleoside Phosphates | 1 | 2011 | 31 | 0.020 |
Why?
| | Adult | 3 | 2024 | 40777 | 0.020 |
Why?
| | Tissue Array Analysis | 1 | 2011 | 49 | 0.020 |
Why?
| | Software | 1 | 2017 | 680 | 0.020 |
Why?
| | Water | 1 | 2014 | 445 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2021 | 4560 | 0.020 |
Why?
| | Gene Silencing | 1 | 2011 | 202 | 0.020 |
Why?
| | Binding, Competitive | 1 | 2010 | 185 | 0.020 |
Why?
| | RNA, Double-Stranded | 1 | 2010 | 51 | 0.020 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2010 | 88 | 0.020 |
Why?
| | Schistosomiasis mansoni | 1 | 2009 | 25 | 0.020 |
Why?
| | RNA Interference | 1 | 2011 | 475 | 0.020 |
Why?
| | DNA, Single-Stranded | 1 | 2010 | 117 | 0.020 |
Why?
| | Molecular Conformation | 1 | 2009 | 141 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 977 | 0.020 |
Why?
| | Mutant Proteins | 1 | 2009 | 105 | 0.020 |
Why?
| | Blotting, Western | 1 | 2011 | 1179 | 0.020 |
Why?
| | Amino Acid Substitution | 1 | 2009 | 302 | 0.020 |
Why?
| | Protein Transport | 1 | 2009 | 442 | 0.020 |
Why?
| | Disease Progression | 1 | 2015 | 2864 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2013 | 3124 | 0.010 |
Why?
| | Molecular Motor Proteins | 1 | 2004 | 37 | 0.010 |
Why?
| | Apoptosis | 1 | 2013 | 2440 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2017 | 8333 | 0.010 |
Why?
| | Gene Expression Profiling | 1 | 2011 | 1767 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2017 | 6066 | 0.010 |
Why?
| | Nucleotides | 1 | 2004 | 129 | 0.010 |
Why?
| | Butanols | 1 | 2003 | 6 | 0.010 |
Why?
| | Protein Subunits | 1 | 2004 | 229 | 0.010 |
Why?
| | Threonine | 1 | 2003 | 44 | 0.010 |
Why?
| | Alcohols | 1 | 2003 | 26 | 0.010 |
Why?
| | Ions | 1 | 2003 | 66 | 0.010 |
Why?
| | Prognosis | 1 | 2011 | 4316 | 0.010 |
Why?
| | Ligands | 1 | 2003 | 665 | 0.010 |
Why?
| | Young Adult | 1 | 2017 | 14219 | 0.010 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2003 | 534 | 0.010 |
Why?
| | Adolescent | 1 | 2017 | 22530 | 0.010 |
Why?
| | Aged | 1 | 2017 | 26153 | 0.010 |
Why?
| | Middle Aged | 1 | 2017 | 36215 | 0.010 |
Why?
|
|
Zhao's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|